Cosmo Mellen

    Managing Director
    Spectrum Therapeutics UK

    Cosmo Feilding Mellen is Managing Director at Spectrum Therapeutics UK, the medical arm of Canopy Growth Corporation, the world’s leading cannabis company

    Previous to this, Cosmo has been a close collaborator of the Beckley Foundation – a UK think tank dedicated to drug policy reform – for almost a decade, and was involved in the formation of the Beckley-Exeter Cannabis Research Program in partnership with Exeter University.